Kevin Young

Former Chief Operating Officer at Gilead Sciences, Inc.

Kevin Young

Kevin Young

Former Chief Operating Officer at Gilead Sciences, Inc.

Biography

Kevin B. Young is on the board of Interplast and Cortexyme, Inc. In his past career Mr. Young held the position of Chief Operating Officer for Gilead Sciences, Inc., Executive Vice President-Commercial Operations at Gilead Sciences, Inc., Principal at Amgen, Inc. and Principal at AstraZeneca Pharmaceuticals LP. Mr. Young received a graduate degree from The University of Nottingham and an undergraduate degree from Liverpool John Moores University.

Overview
Career Highlights

Gilead Sciences, Inc.

RelSci Relationships

2183

Number of Boards

3

Birthday

1958

Age

61

Number of Awards

1

Contact Data
Trying to get in touch with Kevin Young? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Kevin Young likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Patient Officer at Gilead Sciences, Inc.

Relationship likelihood: Strong

Former Executive Vice President, Worldwide Commercial Operations at Gilead Sciences, Inc.

Relationship likelihood: Strong

Former Head-Media Relations at Gilead Sciences, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Akero Therapeutics, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at ReSurge International

Relationship likelihood: Strong

Director at Gilead Sciences Foundation

Relationship likelihood: Strong

Director at Gilead Sciences Foundation

Relationship likelihood: Strong

Former Senior Vice President-Corporate Development & Strategy at Theravance Biopharma, Inc.

Relationship likelihood: Strong

Former Chief Financial Officer at DiagCor Bioscience, Inc. Ltd.

Relationship likelihood: Strong

Director at Gilead Sciences Foundation

Relationship likelihood: Strong

Paths to Kevin Young
Potential Connections via
Relationship Science
You
Kevin Young
Former Chief Operating Officer at Gilead Sciences, Inc.
Education
Graduate Degree in Sports Science & Exercise

The University of Nottingham shares many of the characteristics of the world's great universities. However, they are distinct not only in their key strengths but in how their many strengths combine: they are financially secure, campus based and comprehensive; they are research-led and recruit top students and staff from around the world; they are committed to internationalising all their core activities so their students can have a valuable and enjoyable experience that prepares them well for the rest of their intellectual, professional and personal lives.

Undergraduate Degree in Sports Science & Exercise

Liverpool John Moores University (abbreviated LJMU) is a public research university in the city of Liverpool, England. The university can trace its origins to the Liverpool Mechanics' School of Arts, established in 1823.This later merged to become Liverpool Polytechnic. In 1992, following an Act of Parliament, the Liverpool Polytechnic became what is now Liverpool John Moores University. It is named after Sir John Moores, a local businessman and philanthropist, who donated to the university's precursor institutions.

Executive Program

The University of Michigan (UM, U-M, UMich, or U of M), frequently referred to as simply Michigan, is a public research university located in Ann Arbor, Michigan, United States. It is the state's oldest university and the flagship campus of the University of Michigan. It is one of the original eight Public Ivy universities and is one of the founding members of the Association of American Universities. It has been ranked among the top five research universities in the US, and among the top 20 universities in the world. U-M also has satellite campuses in Flint and Dearborn.

Career History
Chief Operating Officer
Prior - 2018

Since 1987, Gilead Sciences has worked to discover, develop and commercialize medications to advance the care of patients suffering from life-threatening diseases in areas of unmet medical need. In 25 years, Gilead has become a leading biopharmaceutical company with a portfolio of 15 marketed products, a growing pipeline of investigational drugs and approximately 5,000 employees in offices across four continents. Gilead's therapeutic areas of focus include HIV/AIDS, hepatitis, serious respiratory, cardiovascular, and metabolic conditions, cancer and inflammation

Head-US Inflammation Business Unit
Prior

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Professional
Prior

AstraZeneca Pharmaceuticals LP develops, manufactures, and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory, and oncology infections. The company was founded in 1999 and is headquartered in Wilmington, DE.

Boards & Committees
Director
Tenure Unconfirmed
Board Member
Tenure Unconfirmed

Interplast is an American nonprofit company located in Sunnyvale, CA, that provides surgical treatment services.

Political Donations
$1,000
2013

Representative at Office of the Representative from California's 18th District, Anna Eshoo

$1,000
2011

Representative at Office of the Representative from California's 18th District, Anna Eshoo

Awards & Honors
2011
Commander of the Most Excellent Order of the British Empire
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Kevin Young. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Kevin Young's profile does not indicate a business or promotional relationship of any kind between RelSci and Kevin Young.